# Draig Therapeutics

**Canonical:** https://apis.io/providers/draig-therapeutics/  
**Website:** https://draigtherapeutics.com/  
**APIs profiled:** 0

Draig Therapeutics is a clinical-stage biopharmaceutical company developing transformative, best-in-class therapies for major neuropsychiatric disorders, including Major Depressive Disorder. A Cardiff University spinout co-founded with SV Health Investors, Draig ("dragon" in Welsh) leverages its founders' expertise in modulating the core glutamate/GABA pathways that underlie synaptic excitation and inhibition imbalance in the brain. Its pipeline is led by DT-101, a next-generation AMPA receptor positive allosteric modulator (PAM) advancing toward Phase 2 in MDD, alongside DT-201 and DT-301, subtype-selective GABAA receptor modulators. The company launched from stealth in June 2025 with a $140 million (£107 million) oversubscribed Series A led by Access Biotechnology, with participation from Canaan Partners, SR One, Sanofi Ventures, Schroders Capital, SV Health Investors, and ICG. Added to the API Evangelist network as a portfolio company of Canaan Partners.

## Kin Score — 7.1 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 7.1).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Draig Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Therapeutics, Neuroscience, Neuropsychiatry, Drug Discovery, Clinical Stage, CNS

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/draig-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.